Eligibility to lung cancer screening among staffs of a university hospital: A large cross-sectional survey.


Journal

Respiratory medicine and research
ISSN: 2590-0412
Titre abrégé: Respir Med Res
Pays: France
ID NLM: 101746324

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 21 06 2022
revised: 26 09 2022
accepted: 24 10 2022
medline: 9 6 2023
pubmed: 2 2 2023
entrez: 1 2 2023
Statut: ppublish

Résumé

Implementation of Lung cancer screening (LCS) programs is challenging. The ILYAD study objectives is to evaluate communication methods to improve participation rate among the Lyon University Hospital employees. In this first part of the study, we aimed to determinate the number of eligible individuals among our population of employees. In November 2020, we conducted a questionnaire based cross sectional survey among the Lyon University Hospital employees (N = 26,954). We evaluated the PLCO m2012 risk prediction model and the eligibility criteria recommended by French guidelines. We assessed the proportion of eligible individuals among the responders and calculated the total eligible individuals in our hospital. Overall, 4,526 questionnaires were available for analysis. 16.0% were current smokers, and 28.2% were former smokers. Among the 50-75yo ever-smoker employees, 27% were eligible according to the French guidelines, 2.7% of all eversmokers according to a PLCO m2012 score ≥ 1.51%, and thus, 3.8% of the surveyed population were eligible to the combined criteria. The factors associated with higher eligibility among 50-75yo ever-smokers were educational level, feeling symptoms related to tobacco smoking, personal history of COPD and family history of lung cancer. Using the French guidelines criteria only, we estimated the total number of eligible individuals in the hospital at 838. In this study, we determined a theoretical number of eligible employees to LCS in our institution and the factors associated to eligibility. Secondly, we will propose LCS to all eligible employees of Lyon University Hospital with incremented information actions.

Identifiants

pubmed: 36724677
pii: S2590-0412(22)00085-X
doi: 10.1016/j.resmer.2022.100970
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100970

Informations de copyright

Copyright © 2022. Published by Elsevier Masson SAS.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Emmanuel Grolleau (E)

Service de pneumologie aigue et cancérologie thoracique, Hôpital Lyon Sud, Hospices Civils de Lyon, 69310, Pierre Bénite, France; Centre d'Innovation en Cancérologie de Lyon EA 3738, Faculté de médecine Lyon-Sud, Université Lyon 1, 69600, Oullins, France.

Julie de Bermont (J)

Service de pneumologie aigue et cancérologie thoracique, Hôpital Lyon Sud, Hospices Civils de Lyon, 69310, Pierre Bénite, France. Electronic address: Julie.debermont@gmail.com.

Flavien Devun (F)

Unité de Recherche Commune en Oncologie Thoracique, Hospices Civils de Lyon, Lyon, France.

David Pérol (D)

Bureau d'études cliniques, Centre Léon Bérard, Lyon, France.

Véronique Lacoste (V)

Applied Linguistics Research Center, Lyon 2 university, Lyon, France.

Loïc Delastre (L)

Medical Management Department, Hospices Civils de Lyon, Lyon, France.

Fanny Fleurisson (F)

Medical Management Department, Hospices Civils de Lyon, Lyon, France.

Gilles Devouassoux (G)

Service de Pneumologie, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France.

Jean-François Mornex (JF)

Service de Pneumologie, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France.

François Cotton (F)

Service d'Imagerie Médicale, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.

Marie Darrason (M)

Service de pneumologie aigue et cancérologie thoracique, Hôpital Lyon Sud, Hospices Civils de Lyon, 69310, Pierre Bénite, France; Institut de Recherche en Philosophie, Lyon 3 University, Lyon, France.

Martin Tammemagi (M)

Brockes University, Ontario, Canada.

Sébastien Couraud (S)

Service de pneumologie aigue et cancérologie thoracique, Hôpital Lyon Sud, Hospices Civils de Lyon, 69310, Pierre Bénite, France; Centre d'Innovation en Cancérologie de Lyon EA 3738, Faculté de médecine Lyon-Sud, Université Lyon 1, 69600, Oullins, France; Unité de Recherche Commune en Oncologie Thoracique, Hospices Civils de Lyon, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH